Ecor1 Capital, Llc, Ten Percent Owner at Eiger Biopharmaceuticals, holds 13.44M shares in Zymeworks (Ticker: ZYME), holds 3.85M shares in Voyager Therapeutics (Ticker: VYGR), holds 23.17M shares in Prothena (Ticker: PRTA). Most recently, Ecor1 Capital, Llc Bought ― shares of Zymeworks on Jun 21, 2023 for an estimated value of 27.20M.